$JKHY
JACK HENRY & ASSOCIATES INC

2023 Q3 Form 10-K Financial Statement

#000077915223000062 Filed on August 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2023
Revenue $571.4M $534.6M $2.078B
YoY Change 7.97% 10.77% 6.94%
Cost Of Revenue $323.0M $308.9M $1.219B
YoY Change 8.3% 7.69% 8.01%
Gross Profit $248.4M $225.8M $858.6M
YoY Change 7.55% 15.27% 5.45%
Gross Profit Margin 43.47% 42.23% 41.33%
Selling, General & Admin $78.77M $63.07M $235.3M
YoY Change 37.66% 8.54% 7.78%
% of Gross Profit 31.72% 27.94% 27.4%
Research & Development $36.89M $38.50M $142.7M
YoY Change 11.82% 13.36% 17.57%
% of Gross Profit 14.85% 17.05% 16.62%
Depreciation & Amortization $12.05M $48.38M $48.72M
YoY Change -2.93% 8.17% -4.07%
% of Gross Profit 4.85% 21.43% 5.67%
Operating Expenses $115.7M $101.6M $378.0M
YoY Change 28.21% 10.32% 11.28%
Operating Profit $132.7M $124.2M $480.7M
YoY Change -5.7% 19.66% 1.28%
Interest Expense $4.197M -$248.0K $15.07M
YoY Change 166.31% -74.72% 532.26%
% of Operating Profit 3.16% -0.2% 3.14%
Other Income/Expense, Net
YoY Change
Pretax Income $133.2M $124.0M $474.6M
YoY Change -4.34% 20.58% 0.49%
Income Tax $31.57M $26.18M $107.9M
% Of Pretax Income 23.69% 21.12% 22.74%
Net Earnings $101.7M $97.77M $366.6M
YoY Change -4.57% 21.57% 1.03%
Net Earnings / Revenue 17.8% 18.29% 17.65%
Basic Earnings Per Share $1.40 $5.03
Diluted Earnings Per Share $1.39 $1.34 $5.02
COMMON SHARES
Basic Shares Outstanding 72.94M shares 72.88M shares 72.92M shares
Diluted Shares Outstanding 73.01M shares 73.10M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.50M $12.24M $12.24M
YoY Change -1.47% -74.91% -74.91%
Cash & Equivalents $31.47M $12.24M $12.24M
Short-Term Investments
Other Short-Term Assets $215.3M $220.2M $220.2M
YoY Change 18.72% 23.45% 23.45%
Inventory
Prepaid Expenses
Receivables $288.7M $361.3M $388.0M
Other Receivables $0.00 $7.523M $7.523M
Total Short-Term Assets $563.5M $628.0M $628.0M
YoY Change 16.16% 2.35% 2.35%
LONG-TERM ASSETS
Property, Plant & Equipment $202.8M $205.7M $249.3M
YoY Change -2.62% -2.86% -3.58%
Goodwill $804.8M $804.8M
YoY Change 0.08% 17.07%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $334.8M $322.7M $358.9M
YoY Change 11.27% 9.94% 11.42%
Total Long-Term Assets $1.968B $1.940B $2.146B
YoY Change 4.39% 19.01% 16.49%
TOTAL ASSETS
Total Short-Term Assets $563.5M $628.0M $628.0M
Total Long-Term Assets $1.968B $1.940B $2.146B
Total Assets $2.734B $2.774B $2.774B
YoY Change 6.04% 12.96% 12.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.29M $19.16M $19.16M
YoY Change -0.78% -8.93% -8.93%
Accrued Expenses $157.9M $172.6M $172.6M
YoY Change 6.95% -10.11% -10.11%
Deferred Revenue $261.7M $332.0M
YoY Change -4.77% 0.39%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $470.6M $523.8M $523.8M
YoY Change 0.05% -3.69% -3.69%
LONG-TERM LIABILITIES
Long-Term Debt $245.0M $275.0M $275.0M
YoY Change 0.0% 139.13% 139.13%
Other Long-Term Liabilities $52.71M $54.37M $122.1M
YoY Change 2.67% 6.62% -0.29%
Total Long-Term Liabilities $603.7M $641.6M $397.1M
YoY Change -6.69% 21.02% 67.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $470.6M $523.8M $523.8M
Total Long-Term Liabilities $603.7M $641.6M $397.1M
Total Liabilities $1.074B $1.165B $1.165B
YoY Change -3.85% 8.51% 8.51%
SHAREHOLDERS EQUITY
Retained Earnings $2.920B $2.856B
YoY Change 7.85% 8.32%
Common Stock $1.041M $1.041M
YoY Change 0.1% 0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.852B $1.832B
YoY Change 2.49% 1.38%
Treasury Stock Shares
Shareholders Equity $1.660B $1.609B $1.609B
YoY Change
Total Liabilities & Shareholders Equity $2.734B $2.774B $2.774B
YoY Change 6.04% 12.96% 12.96%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2023
OPERATING ACTIVITIES
Net Income $101.7M $97.77M $366.6M
YoY Change -4.57% 21.57% 1.03%
Depreciation, Depletion And Amortization $12.05M $48.38M $48.72M
YoY Change -2.93% 8.17% -4.07%
Cash From Operating Activities $157.1M $174.5M $381.6M
YoY Change 14.84% -14.12% -24.39%
INVESTING ACTIVITIES
Capital Expenditures $7.612M $54.17M $39.18M
YoY Change -1.62% -216.92% 13.04%
Acquisitions $0.00 $229.6M
YoY Change -100.0%
Other Investing Activities $900.0K $54.00K -$202.7M
YoY Change -100.44% -101.08% 3990.6%
Cash From Investing Activities -$50.53M -$54.11M -$409.7M
YoY Change -79.76% 5.44% 108.65%
FINANCING ACTIVITIES
Cash Dividend Paid $37.86M $147.2M
YoY Change 6.03% 5.87%
Common Stock Issuance & Retirement, Net $12.63M
YoY Change -93.07%
Debt Paid & Issued, Net $650.1M
YoY Change 104.98%
Cash From Financing Activities -$87.39M -134.7M -$8.430M
YoY Change -191.08% -5.74% -97.28%
NET CHANGE
Cash From Operating Activities $157.1M 174.5M $381.6M
Cash From Investing Activities -$50.53M -54.11M -$409.7M
Cash From Financing Activities -$87.39M -134.7M -$8.430M
Net Change In Cash $19.22M -14.31M -$36.54M
YoY Change -214.31% -259.17% 1557.32%
FREE CASH FLOW
Cash From Operating Activities $157.1M $174.5M $381.6M
Capital Expenditures $7.612M $54.17M $39.18M
Free Cash Flow $149.5M $120.4M $342.4M
YoY Change 15.83% -51.77% -27.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2022Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
8959000 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
32000 usd
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
150000 usd
CY2023 us-gaap Interest Expense
InterestExpense
15073000 usd
CY2022 us-gaap Interest Expense
InterestExpense
2384000 usd
CY2021 us-gaap Interest Expense
InterestExpense
1144000 usd
CY2023Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
0 usd
CY2022Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
20201000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
627962000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
613524000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
205664000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
211709000 usd
CY2023Q2 us-gaap Deferred Costs
DeferredCosts
161465000 usd
CY2022Q2 us-gaap Deferred Costs
DeferredCosts
143750000 usd
CY2023Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
565714000 usd
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
410957000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
322698000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
293526000 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
19998000 usd
CY2022Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
25137000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
804797000 usd
CY2022Q2 us-gaap Goodwill
Goodwill
687458000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1940200000 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
1630331000 usd
CY2023Q2 us-gaap Assets
Assets
2773826000 usd
CY2022Q2 us-gaap Assets
Assets
2455564000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
19156000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
21034000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
172629000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
192042000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
67000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
331974000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
330687000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
523759000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
543830000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
67755000 usd
CY2022Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
71485000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
244431000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
292630000 usd
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
275000000 usd
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
115000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
54371000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50996000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
641557000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
530111000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
1165316000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1073941000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
104088784 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103921724 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1041000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1039000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
583836000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
551360000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2855751000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2636342000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
31194351 shares
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
31042903 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1832118000 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1807118000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1608510000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1381623000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2773826000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2455564000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1608510000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1381623000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1319292000 usd
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.02
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.90
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.78
CY2023 us-gaap Profit Loss
ProfitLoss
366646000 usd
CY2022 us-gaap Profit Loss
ProfitLoss
362916000 usd
CY2021 us-gaap Profit Loss
ProfitLoss
311469000 usd
CY2023 us-gaap Depreciation
Depreciation
48720000 usd
CY2022 us-gaap Depreciation
Depreciation
50789000 usd
CY2021 us-gaap Depreciation
Depreciation
52515000 usd
CY2023 us-gaap Adjustment For Amortization
AdjustmentForAmortization
142006000 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
126835000 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
123233000 usd
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
48199000 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-31872000 usd
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-16760000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
28611000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
24780000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
20746000 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
4517000 usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-400000 usd
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1988000 usd
CY2023 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
12067000 usd
CY2022 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
41508000 usd
CY2021 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6112000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
112316000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
82565000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
57059000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6277000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6646000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-94000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20453000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1190000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7045000 usd
CY2023 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
9952000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
16704000 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-10927000 usd
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-10547000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6572000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6541000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
381559000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
504631000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
462129000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
229628000 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2300000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
39179000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34659000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22988000 usd
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
27939000 usd
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
45000 usd
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6187000 usd
CY2023 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
1685000 usd
CY2022 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
8491000 usd
CY2021 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
6506000 usd
CY2023 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
166120000 usd
CY2022 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
148239000 usd
CY2021 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
128343000 usd
CY2023 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 usd
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
5000000 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5000000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-409673000 usd
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
200000000 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
650060000 usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
317127000 usd
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
100114000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
193916000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
431529000 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
147237000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
139070000 usd
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
133800000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8505000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4152000 usd
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7721000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12371000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11773000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10931000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8430000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-310492000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-462232000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-36544000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2205000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-162353000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48787000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50992000 usd
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213345000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12243000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48787000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50992000 usd
CY2023Q2 jkhy Entity Number Of Customers
EntityNumberOfCustomers
7500 client
CY2023 us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1800000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1740000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1458000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1389000 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1000 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1000 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7955000 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7616000 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
31194000 shares
CY2023Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
3796000 shares
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1832118000 usd
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
151000 shares
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 usd
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
31043000 shares
CY2022Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
3948000 shares
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P78M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
5897338000 usd
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.25 rate
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.19 rate
CY2023Q2 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
442012000 usd
CY2023 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
154008000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43662000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46869000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
50269000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9776000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40493000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
51452000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10681000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
40771000 usd
CY2023Q2 jkhy Accumulated Amortization Operating Lease Rightofuseasset
AccumulatedAmortizationOperatingLeaseRightofuseasset
34973000 usd
CY2022Q2 jkhy Accumulated Amortization Operating Lease Rightofuseasset
AccumulatedAmortizationOperatingLeaseRightofuseasset
31006000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
11870000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
13058000 usd
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
3608000 usd
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
12127000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
13082000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
13672000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2368000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2407000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4691000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P76M
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0214 rate
CY2022Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
20201000 usd
CY2023Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group
AssetsHeldForSaleNotPartOfDisposalGroup
0 usd
CY2022 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
126835000 usd
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
123233000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
134828000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
113547000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
90663000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
66803000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
40178000 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
67000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
115000000 usd
CY2023 us-gaap Interest Paid
InterestPaid
14776000 usd
CY2022 us-gaap Interest Paid
InterestPaid
1788000 usd
CY2021 us-gaap Interest Paid
InterestPaid
852000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
125622000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
59390000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
55598000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
30505000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
18089000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
13897000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-40218000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
24391000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
14401000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-7981000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
7481000 usd
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2360000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107928000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
109351000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
86256000 usd
CY2023Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
18186000 usd
CY2022Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
15340000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
14023000 usd
CY2022Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
15382000 usd
CY2023Q2 jkhy Deferred Tax Assets Leasing Liability
DeferredTaxAssetsLeasingLiability
12462000 usd
CY2022Q2 jkhy Deferred Tax Assets Leasing Liability
DeferredTaxAssetsLeasingLiability
12868000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1965000 usd
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2107000 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2916000 usd
CY2022Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3311000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49552000 usd
CY2022Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
49008000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
125000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
200000 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
49427000 usd
CY2022Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
48808000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
27788000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
33390000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Other Finite Lived Assets
DeferredTaxLiabilitiesOtherFiniteLivedAssets
136045000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Other Finite Lived Assets
DeferredTaxLiabilitiesOtherFiniteLivedAssets
192187000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
119201000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Tax Deferred Income
DeferredTaxLiabilitiesTaxDeferredIncome
104139000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
10824000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
11722000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
293858000 usd
CY2022Q2 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
341438000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
244431000 usd
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
292630000 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 rate
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 rate
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 rate
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.037 rate
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.043 rate
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.032 rate
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.023 rate
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.020 rate
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.024 rate
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003 rate
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001 rate
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001 rate
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.227 rate
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.232 rate
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217 rate
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
125000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
125000 usd
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
200000 usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
145862000 usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
60553000 usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
80220000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12005000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
10453000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8990000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
8066000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1872000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1234000 usd
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
529000 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
73000 usd
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-310000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
362916000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
311469000 usd
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10112000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1598000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
490000 usd
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
30000 usd
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
3408000 usd
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
8762000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1863000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1642000 usd
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
36000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2570000 usd
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2433000 usd
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
350000 usd
CY2023 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1638000 usd
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
12005000 usd
CY2023 us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
The Company sells its products to banks, credit unions, and financial institutions throughout the United States and generally does not require collateral. Billings to customers are typically due 30 days from date of billing. Reserves are maintained for potential credit losses. Customer-related risks are moderated through the inclusion of credit mitigation clauses in the Company's contracts and through the monitoring of timely payments.
CY2023 us-gaap Concentration Risk Supplier
ConcentrationRiskSupplier
In addition, some of the Company’s key solutions are dependent on technology manufactured by third parties. Termination of the Company’s relationship with one or more of these third parties could have a negative impact on the operations of the Company.
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
28611000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
24780000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
20746000 usd
CY2023 us-gaap Restricted Stock Expense
RestrictedStockExpense
26427000 usd
CY2022 us-gaap Restricted Stock Expense
RestrictedStockExpense
22703000 usd
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
18817000 usd
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5115000 usd
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4252000 usd
CY2021 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3258000 usd
CY2023 jkhy Share Based Payment Arrangement Expense Net Excess Tax Benefit
ShareBasedPaymentArrangementExpenseNetExcessTaxBenefit
1109000 usd
CY2022 jkhy Share Based Payment Arrangement Expense Net Excess Tax Benefit
ShareBasedPaymentArrangementExpenseNetExcessTaxBenefit
652000 usd
CY2021 jkhy Share Based Payment Arrangement Expense Net Excess Tax Benefit
ShareBasedPaymentArrangementExpenseNetExcessTaxBenefit
719000 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
72918000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73324000 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
75546000 shares
CY2023 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
178000 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
24931000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
12139000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
21652000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
366646000 usd
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
162000 shares
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
112000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73096000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73486000 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75658000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.03
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.95
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.12
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.02
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.94
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.12
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10000 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11000 shares
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1 rate
CY2023 jkhy Defined Contribution Plan Employment Length Requirement
DefinedContributionPlanEmploymentLengthRequirement
P6M
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 usd
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 usd
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 usd
CY2023 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
29308000 usd
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
28259000 usd
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
26783000 usd
CY2022Q3 us-gaap Business Combination Acquired Receivables Fair Value
BusinessCombinationAcquiredReceivablesFairValue
978000 usd
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 segment
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2077702000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
1219062000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
142678000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
235274000 usd
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
1597014000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
480688000 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6114000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
474574000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1942884000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1128614000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
121355000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
218296000 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
1468265000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
474619000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2352000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
472267000 usd
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1758225000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
1063399000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
109047000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
187060000 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
1359506000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
398719000 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-994000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
397725000 usd
CY2023 dei Auditor Firm
AuditorFirmId
238

Files In Submission

Name View Source Status
0000779152-23-000062-index-headers.html Edgar Link pending
0000779152-23-000062-index.html Edgar Link pending
0000779152-23-000062.txt Edgar Link pending
0000779152-23-000062-xbrl.zip Edgar Link pending
exhibit-jhapsuawardxex1076.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
formofaircrafttimesharinga.htm Edgar Link pending
jha2006espp-amendedandrest.htm Edgar Link pending
jkhy-20230630.htm Edgar Link pending
jkhy-20230630.xsd Edgar Link pending
jkhy-20230630xex211.htm Edgar Link pending
jkhy-20230630xex231.htm Edgar Link pending
jkhy-20230630xex311.htm Edgar Link pending
jkhy-20230630xex312.htm Edgar Link pending
jkhy-20230630xex321.htm Edgar Link pending
jkhy-20230630xex322.htm Edgar Link pending
jkhy-20230630xex41.htm Edgar Link pending
jkhy-20230630_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
jkhy-20230630_pre.xml Edgar Link unprocessable
jkhy-20230630_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
jkhy-20230630_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
jkhy-20230630_lab.xml Edgar Link unprocessable
jkhy-20230630_def.xml Edgar Link unprocessable